Endo
Testicular Failure
search
Testicular Failure
, Hypogonadism in Men, Testicular Hypogonadism, Male Hypogonadism
See Also
Hypogonadism
Androgen Decline in the Aging Male
Causes
Primary (Testicular)
Hypogonadism
(High LH, high FSH)
Congenital
Klinefelter's Syndrome
5-alpha reductase deficiency
Myotonic dystrophy
Cryptorchidism
(
Undescended Testicle
)
Hemochromatosis
FSH or LH receptor gene mutation
Acquired
Orchiectomy
Bilateral
Orchitis
(mumps,
Gonorrhea
,
Chlamydia
)
Drug or Toxin induced
Hypogonadism
Alcohol
Heavy Metal
s (e.g.
Hemochromatosis
)
Chemotherapy
HIV Infection
or
AIDS
Hypothyroidism
Radiation or
Trauma
to
Testicle
ss
Testicular Torsion
Secondary (Central)
Hypogonadism
(Low LH, low FSH)
Congenital
Kallmann Syndrome
Fertile Eunuch Syndrome
Prader-Willi Syndrome
Acquired
Pituitary Adenoma
or
Prolactinoma
Craniopharingioma
Pituitary surgery
Intracranial radiation (sella radiation)
Chronic Opioid
use
Sleep
deprivation
Surgery or
Trauma
Mixed Cause
Hypogonadism
Male Menopause
(Normal Physiologic response to aging)
Testosterone Level
s normally starting declining after age 40 years old
Testosterone Level
s are low in 50% of age >80 years old
Obesity
Type II Diabetes Mellitus
Chronic Obstructive Pulmonary Disease
(
COPD
)
Chronic Kidney Disease
Cirrhosis
HIV Infection
or
AIDS
Symptoms
Sexual Dysfunction
Decreased libido (erectile function often intact)
Decreased sexual activity
Decreased facial and body hair
Decreased
Muscle Strength
and decreased
Muscle
mass
Fatigue
, low energy or lethargy
Depressed mood
Mild Cognitive Impairment
Increased visceral fat
Hot Flashes
or sweats
Signs
Prepubertal Onset
Hypoplastic penis and
Testes
Thin, smooth skin
Voice does not deepen
Female distribution of pubic hair
Absence of beard
Poor
Muscle
development
Long limbs
Broad hips
Gynecomastia
Postpubertal Onset
Testicular atrophy (small
Testes
) and pallor
Reduced body hair
Increased visceral fat
Decreased libido
Decreased spontaneous
Erection
or
Impotence
Infertility
Decreased
Muscle
mass, physical strength or physical work performance
Decreased
Bone Mineral Density
(low impact mechanism for
Fracture
)
Increased body fat or
Body Mass Index
(BMI)
Imaging
Prepubertal delay in epiphyseal closure
Labs
Serum Androgens
Testosterone
Decreased in all cases (<300 ng/dl or 10.4 nmol/L)
Obtain in the morning (or within 2 hours of awakening) due to circadian variation
Leutinizing
Hormone
(LH)
Primary Testicular Failure: High LH
Central failure: Low LH
Follicle Stimulating Hormone
(FSH)
High level suggests irreversible
Hypogonadism
GnRH
Secondary cause
Urine 17-Ketosteroids
Secondary effects of
Hypogonadism
Complete Blood Count
Anemia
(normocytic and normochromic)
Diagnosis
Precautions
Do not evaluate for
Hypogonadism
in patients without signs or symptoms
Questionnaires (e.g. Aging Males Symptoms) are inadequate alone to indicate
Hypogonadism
testing
Emmelot-Vonk (2011) Clin Endocrinol 74(4): 488-94 [PubMed]
Protocol: Symptoms and signs suggestive of
Hypogonadism
Morning
Total Testosterone
decreased (<300 ng/dl)
Confirm with a second morning
Total Testosterone
If borderline
Total Testosterone
, consider additional testing
Consider
Free Testosterone
Consider
Sex Hormone Binding Globulin
(
SHBG
), affected by aging,
Obesity
,
Diabetes Mellitus
Additional testing if low testerone confirmed
Obtain LH and FSH levels, and interpret as below
Primary Hypogonadism
(Testicular)
Leutinizing
Hormone
(LH) elevated
Follicle Stimulating Hormone
(FSH) elevated
Testosterone Level
decreased (<300 ng/dl)
Consider chromosomal testing in early age-onset
Hypogonadism
Secondary Hypogonadism
(Central)
Leutinizing
Hormone
(LH) decreased
Follicle Stimulating Hormone
(FSH) decreased
GnRH may be decreased
Testosterone Level
decreased (<300 ng/dl)
Consider pituitary evaluation (
Serum Prolactin
, Brain MRI)
Consider drug-induced (
Alcohol
,
Chemotherapy
) or systemic causes of
Hypogonadism
Eliminate other causes
Urine 17-Ketosteroids normal
Management
See
Androgen Replacement
Precautions:
Erectile Dysfunction
Phosphodiesterase-5 Inhibitors (
PDE5 Inhibitor
s, e.g.
Viagra
) is the first-line treatment
Androgen Replacement
may be considered in low
Testosterone
if
PDE5 Inhibitor
s fail
Avoid
Androgen Replacement
in
Erectile Dysfunction
when
Testosterone Level
s are normal
Complications of untreated Hypogonadism
Osteoporosis
Diminished
Muscle Strength
and other androgen effects
References
Petering (2017) Am Fam Physician 96(7): 441-9 [PubMed]
Type your search phrase here